title: Clinical trials with recombinant allergens--three perspectives: industry.
authors.affiliation: Allergopharma Joachim Ganzer KG, Reinbek.
authors.forename: Annemie
authors.initials: A
authors.lastname: Narkus
authors.forename: Frans
authors.initials: F
authors.lastname: Kniest
authors.forename: Anja
authors.initials: A
authors.lastname: Menzel
authors.forename: Hanns
authors.initials: H
authors.lastname: Meyer
authors.forename: Viola
authors.initials: V
authors.lastname: Sprung
mesh_terms: D000485:Allergens / Q000008:administration & dosage / Q000627:therapeutic use*; D052179:Antigens, Plant / Q000008:administration & dosage / Q000627:therapeutic use; D029662:Betula / Q000009:adverse effects / Q000276:immunology; D003888:Desensitization, Immunologic / Q000379:methods*; D004345:Drug Industry; D006801:Humans; D010940:Plant Proteins / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D011058:Pollen / Q000276:immunology; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology / Q000628:therapy
chemical_list: D000485:Allergens; D052179:Antigens, Plant; D010940:Plant Proteins; D011994:Recombinant Proteins